ALT - Overview: Alanine Aminotransferase (ALT) (GPT), Serum
Diagnosis and monitoring of liver disease associated with hepatic necrosis
BUTAS - Overview: Butalbital, Serum
Monitoring butalbital therapy
BUN - Overview: Blood Urea Nitrogen (BUN), Serum
Screening test for evaluation of kidney function
CRSBF - Overview: Crystal Identification, Body Fluid
Identifying the presence and type of crystals in body fluid
FDA1S - Overview: Drugs of Abuse (10 panel) and Alcohol Screen, Serum
Drugs of Abuse (10 panel) and Alcohol Screen, Serum
CL - Overview: Chloride, Serum
Evaluation of water, electrolyte, and acid-base status
CSU - Overview: Chyluria Screen, Random, Urine
Aiding in the diagnosis of chyluria (galacturia)
EOSU1 - Overview: Eosinophils, Random, Urine
Investigation of possible acute interstitial nephritis
FGHTP - Overview: Ghrelin Total (Plasma)
Ghrelin Total (Plasma)
GLSF - Overview: Glucose, Spinal Fluid
Investigating possible central nervous system infection
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...